Continuous Enteral Rehydration by Nasogastric Tube With ORS in Children With Acute Gastroenteritis
- Conditions
- Acute GastroenteritisDehydration
- Registration Number
- NCT04555200
- Lead Sponsor
- University Hospital, Brest
- Brief Summary
When oral rehydration is impossible, enteral rehydration via the nasogastric route has been the recommended method of rehydration since 2008 by ESPGHAN ( European Society for Paediatric Gastroenterology Hepatology and Nutrition ), for children with acute gastroenteritis. However, these recommendations are rarely followed in France. These recommendations were not applied in the Children's Emergency Department of BREST University Hospital. The investigators changed the protocol and shared it with the caregivers of the emergency unit. The investigators studied the impact of this change of protocol
- Detailed Description
The main purpose was to assess the proportion of children rehydrated by nasogastric tube(NG) after protocol change. Secondary outcomes were to assess hospital length of stay and sides effects.
It is a retro and prospective study. The first phase took place from June to September 2018 and the second from June to September 2019. Any child presenting to pediatric emergencies for acute gastroenteritis requiring nonoral rehydration was included.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 88
Any child presenting to pediatric emergencies for acute gastroenteritis requiring nonoral rehydration was included
- acute gastroenteritis on return from tropical countries
- child with endocrine system diseases requiring parenteral rehydration
- history of chronic pathology requiring enteral feeding
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of nasogastric tube after changing gastroenteritis rehydration protocol 4 months assessed by the number of NG tube and IV in each group
- Secondary Outcome Measures
Name Time Method Hospital lenght of stay between each group 4 months evaluate by administrative data of each case (arrival time and departure time)
Number of Participants With Treatment-Related Adverse Events for each method 4 months Serious sides effect were death and epilptic seizure. Mild sides effects were multiple (IV or NG ripped out, vomiting, failure...).
Trial Locations
- Locations (1)
CHRU de Brest (urgences pédiatriques)
🇫🇷Brest, France